Is a complete TPEX/6547 research report available?

No complete published report is available for tpex/6547 (TPEX/6547) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

tpex/6547 stock profile: metrics, valuation and analysis

Market cap	19.3B
Revenue (ttm)	573.8M
Net income (ttm)	-166.8M
EPS (ttm)	-NT$0.51
Shares out	328.7M
P/E (forward)	63.9x
Volume	143,000
Beta	0.00

All TPEX/6547 indicators

Market & fundamental data

Available fields

191

Groups with data

Currency

TWD

Showing 191 of 191 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	103
Employees Change	15%
Employees Change Percent	17.05
Enterprise value	TWD 18.4B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Industry PE Fwd	32.5
Isin	TW0006547003
Last refreshed	2026-09-12
Market cap	TWD 19.3B
Price	TWD 58.8
Price currency	TWD
Rev Per Employee	5,571,339.81x
Sector	Healthcare
Sector PE	88.31
Sector PE Fwd	27.72
Sic	2836
Symbol	tpex/6547
Website	https://www.medigenvac.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.86%
EV/Sales	32.05x
FCF yield	-1.13%
Forward P/E	63.91x
P/B ratio	5.44x
P/S ratio	33.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-31.56%
EBITDA Margin	-10.08%
Gross margin	63%
Gross Profit	TWD 361.5M
Gross Profit Growth	-6.62%
Gross Profit Growth Q	-7.14%
Gross Profit Growth5 Y	119.26%
Net Income	TWD -166.8M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-29.06%
Profit Margin	-29.06%
Profit Per Employee	TWD -1.6M
Profitable Quarters	TWD 1
ROA	-2.54
Roa5y	-3.7
ROCE	-3.91
ROE	-4.62
Roe5y	-6.04
ROIC	-2.62

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	11.57%
Cagr1y	51.59%
Cagr3y	-7.12%
Cagr5y	-21.06%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	-9.22x
Revenue Growth Q	-20.59x
Revenue Growth Qo Q	8.6x
Revenue Growth Years	3x
Revenue Growth3 Y	181.14x
Revenue Growth5 Y	110.3x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.13
Assets	TWD 4.8B
Cash	TWD 2B
Current Assets	TWD 2.8B
Current Liabilities	TWD 125.1M
Debt	TWD 1.1B
Debt Equity	TWD 0.31
Debt FCF	TWD -5.07
Equity	TWD 3.6B
Interest Coverage	-13.34
Liabilities	TWD 1.2B
Long Term Assets	TWD 2B
Long Term Liabilities	TWD 1.1B
Net Cash	TWD 936.8M
Net Cash By Market Cap	TWD 4.85
Net Cash Growth	-33.09%
Net Debt Equity	TWD -0.26
Tangible Book Value	TWD 3.5B
Tangible Book Value Per Share	TWD 10.76
WACC	4.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	22.37
Inventory Turnover	0.41
Net Working Capital	TWD 656.9M
Quick ratio	17.43
Working Capital	TWD 2.7B
Working Capital Turnover	TWD 0.23

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	198.75%
1Y total return	51.55%
200-day SMA	45.59
3Y total return	-19.89%
50-day SMA	52.61
50-day SMA vs 200-day SMA	50over200
5Y total return	-69.35%
All Time High	281.2
All Time High Change	-79.09%
All Time High Date	2021-05-17
All Time Low	16.19
All Time Low Change	263.28%
All Time Low Date	2015-10-28
ATR	3.43
Beta	0
Beta1y	-0.57
Beta2y	-0.19
Ch YTD	55.76
High	62.4
High52	72.2
High52 Date	2026-09-10
High52ch	-18.56%
Low	58.7
Low52	33.5
Low52 Date	2025-11-06
Low52ch	75.52%
Ma50ch	11.76%
Price vs 200-day SMA	28.98%
RSI	51.32
RSI Monthly	55
RSI Weekly	63.52
Sharpe ratio	0.98x
Sharpe Ratio3y	0.14x
Sharpe Ratio5y	-0.25x
Sortino ratio	1.79
Sortino Ratio3y	0.37
Sortino Ratio5y	-0.25
Total Return	-0.01%
Tr YTD	55.76
Tr1m	13.3%
Tr1w	-4.39%
Tr3m	24.71%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	257,514,426%
Net Borrowing	767,649,000
Shares Insiders	0.49%
Shares Institutions	2.56%
Shares Out	328,749,050
Shares Qo Q	0%
Shares Yo Y	0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -257.2M
Adjusted OCF	-94,947,000
Average Volume	6,935,031.15x
Bv Per Share	10.81
CAPEX	TWD -162.2M
Ch10y	186.3
Ch1m	13.3
Ch1w	-4.39
Ch1y	51.55
Ch3m	24.71
Ch3y	-19.89
Ch5y	-69.46
Ch6m	57.64
Change	-4.23%
Change From Open	-4.55
Close	61.4
Days Gap	0.33
Depreciation Amortization	123,275,000
Dollar Volume	8,408,400
Earnings Date	2026-11-12
EBIT	TWD -181.1M
EBITDA	TWD -57.8M
EPS	TWD -0.51
F Score	3
FCF	TWD -217.6M
FCF EV Yield	-1.18x
FCF Per Share	TWD -0.66
Financing CF	767,649,000
Fiscal Year End	December
Founded	2,012
Investing CF	-573,521,000
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2026-06-30
Last Split Date	2022-08-03
Last Split Type	Forward
Ma150	48.07
Ma150ch	22.32%
Ma20	59.52
Ma20ch	-1.21%
Net CF	138,784,000
Next Earnings Date	2026-11-12
Open	61.6
Position In Range	2.7
Ppne	1,410,058,000
Price Date	2026-09-11
Ptbv Ratio	5.46
Relative Volume	0.02x
Revenue	573,848,000x
SBC By Revenue	6.9x
Share Based Comp	39,603,000
Tr6m	57.64%
Volume	143,000
Z Score	7.48

TPEX/6547 (TPEX/6547)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/6547

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/6547 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TPEX/6547

Frequently asked questions